Drug-Induced Lupus Erythematosus Associated with Proton Pump Inhibitor
| Autor: | Sathiyanarayanan Janakiraman, Ram Arvind Viswanathan, Manokaran Chinnusamy, Roshna Elayidath |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Lupus erythematosus Systemic lupus medicine.drug_class business.industry Proton-pump inhibitor medicine.disease Dermatology Subacute cutaneous lupus immune system diseases medicine skin and connective tissue diseases Drug-induced lupus erythematosus business Cutaneous lupus |
| Zdroj: | Journal of Health and Allied Sciences NU. 10:132-134 |
| ISSN: | 2582-4953 2582-4287 |
| DOI: | 10.1055/s-0040-1716601 |
| Popis: | Drug-induced lupus erythematosus is an autoimmune phenomenon where the drug exposure leads to the development of systemic lupus erythematous like clinical features. Drug-induced lupus erythematosus can be divided into systemic lupus erythematous, subacute cutaneous lupus erythematous, and chronic cutaneous lupus erythematous. Here, we report a case of a 29-year-old female presented with systemic lupus erythematous due to chronic use of proton pump inhibitors, which is considered to be very rare. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|